MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Changing expectations affect investors despite unchanged fundamentals: Weaker underlying volumes.
By Stephen Simpson
Covidien shares are down nearly 7% today on a 12% profit decline for the medical device and pharmaceuticals company.
Covidien (NYSE:COV) shares are under pressure from investors this morning after the company reported a profit decline for its fiscal 2nd quarter.
The MassDevice Career Connector is booming. Check out some of the open jobs at Covidien and other medical device companies.
The medical device industry is looking for a few good men and women.
Advocacy group Consumers Union asks the FDA to reclassify a slate of high-risk implantable medical devices to require more stringent clinical testing and regulatory oversight.
MASSDEVICE ON CALL — Consumer advocacy group Consumers Union submitted a letter to U.S. healthcare regulators, offering more than 11,000 signatures in favor of more stringent oversight of implantable medical devices.
CU urged the FDA to require that all high-risk medical implants undergo clinical testing vie the agency's premarket approval process, rather than allowing them through via the less-stringent 510(k) pathway, which requires only that a device demonstrate that it's "substantially equivalent" to a product already cleared by the FDA.
Medical device giant Covidien recalls a series of ventilator batteries over reports that they may emit false alarms and prematurely switch to back-up supplies.
Massachusetts-based medical device maker Covidien (NYSE:COV) announced a voluntary recall of certain Power Pac batteries distributed with its Newport HT70 and HT70 Plus ventilators, according to an FDA notice.
Covidien to market Vida Diagnostics' Apollo lung imaging system alongside its iLogic pulmonary navigation system.
Covidien (NYSE:COV) and Vida Diagnostics inked a deal for distribution of Vida's Apollo pulmonary imaging system.
The move is aimed at complimenting Mansfield, Mass.-based Covidien's pulmonary portfolio, including its i-Logic lung navigation system.